168.32 -0.56 (-0.33%)
After hours: 5:10PM EDT
|Bid||168.53 x 1000|
|Ask||169.18 x 1000|
|Day's range||168.28 - 170.85|
|52-week range||133.65 - 173.65|
|Beta (5Y monthly)||0.72|
|PE ratio (TTM)||29.83|
|Earnings date||21 Jul 2021|
|Forward dividend & yield||4.24 (2.57%)|
|Ex-dividend date||24 May 2021|
|1y target est||186.80|
Dr. Sejal Hathi, Physician & Clinical Fellow at Massachusetts General Hospital & host of “Civic Rx” podcast, joined Yahoo Finance to discuss the lastest on covid-19.
Halozyme (HALO) first-quarter earnings and sales beat estimates. The company retains 2021 guidance.
Smart Beta ETF report for QUS